Company / Current Liabilities
MAXCYTE, INC. Current Liabilities History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$14.3M
FY2025
5-year range
$14.3M / $17.9M
FY2021-FY2025
Trend
-9.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $18M to $14M over the past 2 years.
Based on SEC 10-K filings.
$14M in FY2025 with a 3-year CAGR of -2.6%.
Improved from $18M to $14M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -2.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -2.6%, indicating a declining trend.
- In FY2025, current liabilities decreased 9.6% year-over-year.
- Peak current liabilities was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.3M | -9.6% |
| FY2024 | $15.8M | -11.6% |
| FY2023 | $17.9M | +15.7% |
| FY2022 | $15.4M | -1.2% |
| FY2021 | $15.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026